Abiopharma

🔍 de Meirelles Wolff Elio Gil (Executive)

Company: AXIA Energia S.A. (AXIA3)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 58,712 shares of Common Shares at $54.18 per share (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 84,623.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 58,712 shares of Stock Options at $54.18 per share (Derivative)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 742,432.00 | transaction_form_type: 4 | Footnotes: F3, F1, F4, F5
• Holds 240,338 shares of Stock Options at $42.0 per share (Derivative)
  Date: 2026-06-26 | Code: H | shares_owned_after: 240,338.00 | Footnotes: F3, F6, F4, F5

Footnotes:

• F1: The exercise price is R$54.18 per share accrues interest at a rate of 5% per annum from grant date to exercise date and is subject to certain other adjustments.
• F2: Represents the sum of (i) vested RSUs (net of withholding tax); (ii) unvested RSUs; and (iii) common shares held by the reporting person.
• F3: The stock options were issued pursuant to AXIA Energia S.A.'s restricted share based compensation program. Exercise is conditioned up the achievement of certain performance goals, as set forth in the award agreement, and the satisfaction of certain other conditions.
• F4: 1/3 of the stock options vest 3 years from grant date, with the remaining vesting on the 4th and 5th anniversaries from grant date, subject to certain conditions, as set forth in the award agreement.
• F5: The reporting person must exercise vested options within 120 days after each respective maturity period, failing which the options lapse. Upon exercise, the reporting person is subject to a lock-up period of 180 calendar days during which the shares may not be sold, transferred, or encumbered.
• F6: The exercise price is R$42.00 per share accrues interest at a rate of 5% per annum from grant date to exercise date and is subject to certain other adjustments.
• REMARKS: *Executive Vice-President of Strategy and Business Development